Aescap is an investor in life sciences companies

Aescap Fund 1 started to built a life sciences portfolio of companies back in 2006. So far the fund has sold two of its portfolio companies to two Nasdaq listed biotech companies and another company has been taken public on Euronext. Today its portfolio consists of 8 private life sciences companies, all based in Europe. The Fund is supported by the European Communities Growth and Employment Initiative, MAP - ETF Start up Facility. 

Aescap2.0, a new initiave, is a fund which is raising money to invest in the most promising public life sciences companies around the globe. 

For more information do not hesistate to contact us. Call managing partner Patrick Krol at +31 20 570 29 40.